Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia

Condition:   AchromatopsiaIntervention:   Drug: rAAV.hCNGA3Sponsors:   STZ eyetrial;   University Hospital TuebingenRecruiting - verified November 2015

Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials